Mitosure®
Mitochondrial Assessment in Embryos
Menu
During embryogenesis, from fertilization to blastocyst formation, no new mitochondria are generated. Instead, embryos rely on maternal mitochondria present in the oocyte to provide energy needed for cell division. Good quality oocytes containing optimal mitochondrial load and sufficient levels of ATP appear to produce higher quality blastocysts.
Furthermore, recent research suggests a correlation between abnormally high mtDNA and poor embryo implantation potential. Consequently, embryos that are chromosomally normal are less likely to implant and develop if they contain abnormally high levels of mitochondrial DNA.
Progenesis Inc.
Address: 4150 Regents Park Row,
Suite 245,
La Jolla, CA 92037
Phone: (858) 257-2122
Fax: (888) 810-6079
Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.
